PinCell
Discovery and early development of innovative molecules for rare immune-mediated, inflammatory and neoplastic skin diseases
- Stage Prototype Ready
- Industry Biotechnology
- Location Modena, Province of Modena, Italy
- Currency EUR
- Founded 2008
- Incorporation Type Not Incorporated
- Website pincell.it
Company Summary
PinCell aims to bridge the gap between basic/clinical research and discovery of new drugs in dermatology. Over twenty-year work in the laboratory from which PinCell was originated has allowed to clarify several mechanisms underlying the processes of a number of cutaneous diseases, particularly of rare diseases. These novel pathomechanisms represent the target for new therapeutic molecules.
Team
-
FounderProfessor of Dermatological Applications of Medical Biotechnologies
Biologist and Clinical Pathologist with 25-year research experience in basic and clinical research in dermatology. Long-standing skill in 3D- culture systems and disease model development.
Faculty member of the PhD program in Molecular and Regenerative Medicine.
Inventor of 3 international patents -
Founder - CMOProfessor of Dermatology with 35-years clinical and research experience.
Chief of the Laboratory of Cutaneous Biology at the University of Modena and Reggio Emilia for 25 years with a proven track record.
Inventor of 4 international patents on drugs (one in Phase II), prior to PinCell.
Organizer and Faculty of “Entrepreneurs in Clinical Academia” at INSEAD Business School. -
Project ManagerFocused in translational research from idea to proof-of-concept in vivo.
Executive Program in Entrepreneurial Studies in Clinical Academia, INSEAD Business School, France.
Biotechnologist and Clinical Pathologist with 15-year research experience in basic and applied research, with particular interest in inflammatory and immune-mediated skin diseases. Long-standing skill in “in vivo” disease models.
PhD in Molecular and Regenerative Medicine.
Advisors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.